Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Buisman, Anne M
Kimman, Tjeerd G
Conyn- van Spaendonck, Marina A E
MetadataShow full item record
TitlePoliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
PubliekssamenvattingBACKGROUND: Dutch people born between 1925 and 1945 were ineligible for vaccination with the inactivated poliovirus vaccine (IPV) introduced in 1957 and may have escaped natural infection because of reduced poliovirus circulation. We examined whether people with low or undetectable antibody levels are susceptible to infection and whether memory immunity provides protection against virus excretion. METHODS: A total of 429 elderly participants were challenged with monovalent oral poliovirus vaccine (type 1 or 3) and followed for 8 weeks. Immune responses and virus excretion were compared for 4 groups, defined on the basis of seronegativity for poliovirus type 1 or 3, natural immunity, and IPV-induced immunity. RESULTS: On the basis of the rapidity of the antibody response and the absence of immunoglobulin M, we saw clear evidence of memory immune responses in 33% of the participants without detectable antibodies against poliovirus type 1 and in 5% of the participants without detectable antibodies against poliovirus type 3. Fecal virus-excretion patterns were not significantly different for seronegative participants, regardless of whether they showed evidence of memory immunity. CONCLUSIONS: Rapid antibody responses after challenge with oral polio vaccine provide evidence for poliovirus-specific memory immunity in seronegative elderly people. However, in contrast to preexisting immunity, memory immunity does not protect against virus excretion. These results have important implications for the poliomyelitis-eradication initiative, in particular for future immunization policies after eradication has been achieved.
- Preexisting poliovirus-specific IgA in the circulation correlates with protection against virus excretion in the elderly.
- Authors: Buisman AM, Abbink F, Schepp RM, Sonsma JA, Herremans T, Kimman TG
- Issue date: 2008 Mar 1
- Anomalous observations on IPV and OPV vaccination.
- Authors: John TJ
- Issue date: 2001
- Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
- Authors: Herremans TM, Reimerink JH, Buisman AM, Kimman TG, Koopmans MP
- Issue date: 1999 Apr 15
- Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
- Authors: Swartz TA, Green MS, Handscher R, Sofer D, Cohen-Dar M, Shohat T, Habib S, Barak E, Dror Z, Somekh E, Peled-Leviathan T, Yulzari R, Libling A, Mendelson E, Shulman LM
- Issue date: 2008 Feb 20
- Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
- Authors: O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, Clemens R, Orenstein W, Jimeno J, Rüttimann R, Costa Clemens SA, Chilean IPV/bOPV study group.
- Issue date: 2015 Nov